Stockreport

Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds

Vivos Therapeutics, Inc.  (VVOS) 
PDF LITTLETON, Colo., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (Nasdaq: VVOS), a leading medical device and healthcare servic [Read more]